HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wolf, C. Articles by Roux, C. Search for Related Content PubMed PubMed Citation Articles by Wolf, C. Articles by Roux, C. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 1325-1333, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Changes in serum sterols of rats treated with 7-dehydrocholesterol- delta 7-reductase inhibitors: comparison to levels in humans with Smith- Lemli-Opitz syndrome

C Wolf, F Chevy, J Pham, M Kolf-Clauw, D Citadelle, N Mulliez and C Roux
Laboratoire de Biochimie, CHU Saint Antoine, Paris.

The impaired conversion of 7-dehydrocholesterol to cholesterol, as a result of a permanent inhibition of the activity of 7- dehydrocholesterol-delta 7-reductase, has been reported in the Smith- Lemli-Opitz (SLO) syndrome (1, 2). For the purpose of experimental teratology, an animal disease model consisting of the offspring of pregnant rats treated with AY 9944 or BM 15766, inhibitors of 7- dehydrocholesterol-delta 7-reductase, was established. The present study compares the profiles of sterols in rat serum, obtained after transient treatment with inhibitors, with profiles of sterols obtained from patients with the permanent enzyme defect. AY 9944 (single dose of 50, 75, or 100 mg/kg) or BM 15766 (60, 75, or 90 mg/kg per day for 11 days) induces hypocholesterolemia and accumulation of 7- dehydrocholesterol and aberrant sterols in rat serum. The aberrant sterols in the treated rats are similar to those detected in human SLO patients by gas chromatography coupled to mass spectrometry (1, 3, 4) and were identified as 7- and 8-dehydrocholesterol, two trienols (I and II), and 19-nor-5,7,9(10)-cholestatrien-3 beta-ol. The time- and dose- dependences of the biochemical alterations are compared to the teratogenic abnormalities induced by inhibitors. The dietary cholesterol supplementation that suppresses embryo malformations induced by AY 9944 prevents severe hypocholesterolemia and decreases the aberrant sterol levels. As a function of time after intoxication, the 8-dehydrocholesterol to 7-dehydrocholesterol ratio increases, suggested that 8-dehydrocholesterol is derived from the gradual conversion of the accumulated 7-dehydrocholesterol. The ratio of 8- dehydrocholesterol to 7-dehydrocholesterol is higher in human SLO than in the animal disease model. This may be explained by a permanent block in 7-dehydrocholesterol-delta 7-reductase in SLO compared to a transient inhibition of this enzyme in the animal model.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. J. Fliesler, N. S. Peachey, M. J. Richards, B. A. Nagel, and D. K. Vaughan Retinal Degeneration in a Rodent Model of Smith-Lemli-Opitz Syndrome: Electrophysiologic, Biochemical, and Morphologic Features Arch Ophthalmol, August 1, 2004; 122(8): 1190 - 1200. [Abstract] [Full Text] [PDF]

				G. E. Herman Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes Hum. Mol. Genet., April 2, 2003; 12(90001): R75 - 88. [Abstract] [Full Text] [PDF]

				F. Chevy, F. Illien, C. Wolf, and C. Roux Limb malformations of rat fetuses exposed to a distal inhibitor of cholesterol biosynthesis J. Lipid Res., August 1, 2002; 43(8): 1192 - 1200. [Abstract] [Full Text] [PDF]

				B. Lindenthal, T. A. Aldaghlas, J. K. Kelleher, S. M. Henkel, R. Tolba, G. Haidl, and K. von Bergmann Neutral sterols of rat epididymis: high concentrations of dehydrocholesterols in rat caput epididymidis J. Lipid Res., July 1, 2001; 42(7): 1089 - 1095. [Abstract] [Full Text] [PDF]

				B. Ruan, W. K. Wilson, J. Pang, N. Gerst, F. D. Pinkerton, J. Tsai, R. I. Kelley, F. G. Whitby, D. M. Milewicz, J. Garbern, et al. Sterols in blood of normal and Smith-Lemli-Opitz subjects J. Lipid Res., May 1, 2001; 42(5): 799 - 812. [Abstract] [Full Text]

				W. Gaoua, C. Wolf, F. Chevy, F. Ilien, and C. Roux Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model J. Lipid Res., April 1, 2000; 41(4): 637 - 646. [Abstract] [Full Text]

				W. Gaoua, F. Chevy, C. Roux, and C. Wolf Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: a model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome J. Lipid Res., March 1, 1999; 40(3): 456 - 463. [Abstract] [Full Text]

				F. F. Moebius, B. U. Fitzky, J. N. Lee, Y.-K. Paik, and H. Glossmann Molecular cloning and expression of the human Delta 7-sterol reductase PNAS, February 17, 1998; 95(4): 1899 - 1902. [Abstract] [Full Text] [PDF]

				J. Incardona, W Gaffield, R. Kapur, and H Roelink The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction Development, January 9, 1998; 125(18): 3553 - 3562. [Abstract] [PDF]